<PAGE>   1

                                    FORM 8-A


                             WASHINGTON, D.C. 20549

                     PURSUANT TO SECTION 12(B) OR (G) OF THE
                         SECURITIES EXCHANGE ACT OF 1934

                             Pain Therapeutics, Inc.
             (Exact name of Registrant as specified in its charter)

<S>                                         <C>                       <C>
               Delaware                                  91-1911336
----------------------------------------    ------------------------------------
(State of Incorporation or organization)    (I.R.S. Employer Identification No.)

250 East Grand Avenue, Suite 70, South San Francisco, California        94080
----------------------------------------------------------------      ----------
            (Address of principal executive offices)                  (Zip Code)

Securities to be registered pursuant to Section 12(b) of the Act:

       Securities to be registered pursuant to Section 12(g) of the Act:

                         COMMON STOCK, $0.001 PAR VALUE

<PAGE>   2

Item 1. Description of Registrant's Securities to be Registered.

     Incorporated by reference to Description of Capital Stock section and
     Shares Eligible for Future Sales sections on pages 54 to 59 of the
     Registrant's Registration Statement on Form S-1 filed with the Securities
     and Exchange Commission on March 14, 2000, as amended (file number
     333-32370) (the "S-1 Registration Statement").

Item 2. Exhibits.

     The following exhibit is filed as a part of this Registration Statement:

<S>            <C>

     *1.1      Specimen of Registrant's Common Stock Certificate.

     *2.1      Form of Amended and Restated Certificate of Incorporation of
               Registrant to be filed with the Secretary of State of Delaware 
               upon closing of the Registrant's initial public offering.
     *2.2      Form of Amended and Restated By Laws of Registrant to be in
               effect upon closing of Registrant's initial public offering.     

     *2.3      Second Amended and Restated Investors' Rights Agreement dated
               February 1, 2000 between Registrant and the holders of its Series
               B and C redeemable convertible preferred stock.

* Incorporated by reference to the Exhibits to the S-1 Registration Statement.


<PAGE>   3


Pursuant to the requirements of Section 12 of the Securities Exchange Act of
1934, the Registrant has duly caused this registration statement to be signed on
its behalf by the undersigned, thereto duly authorized.

Dated: March 14, 2000                   Pain Therapeutics, Inc.

                                        By: /s/ REMI BARBIER
                                           Remi Barbier,
                                           President, Chief Executive Officer
                                           And Chairman